Fuchs O, Pfarr N, Pohlenz J, Thanner F, Schmidt H
Dr. von Hauner University Children's Hospital, Pediatric Endocrinology and Medical Genetics, Munich, Germany.
J Pediatr Endocrinol Metab. 2008 Nov;21(11):1093-7. doi: 10.1515/jpem.2008.21.11.1093.
Congenital primary hypothyroidism occurs in one out of 4,000 births. About 20% of cases are due to defects in thyroid hormonogenesis. We report on a German girl with congenital hypothyroidism due to a mutation in the thyroid peroxidase (TPO) gene who had elevated serum levels of thyroglobulin during periods of hyperthyrotropinemia.
The TPO gene was sequenced directly from genomic DNA.
The patient had a novel homozygous mutation (R314W) in the TPO gene. The unaffected parents were non-consanguineous and both heterozygous carriers of the mutation. Fifty normal individuals did not harbor the mutation ruling out a common polymorphism.
The identified TPO gene mutation (R314W) is very likely the genetic cause for hypothyroidism in the reported child. R314W has not been described before and codes for a presumably inactive TPO molecule.
先天性原发性甲状腺功能减退症在每4000例出生中出现1例。约20%的病例归因于甲状腺激素生成缺陷。我们报告了一名患有先天性甲状腺功能减退症的德国女孩,其甲状腺过氧化物酶(TPO)基因发生突变,在促甲状腺激素血症期间血清甲状腺球蛋白水平升高。
直接从基因组DNA对TPO基因进行测序。
该患者TPO基因存在一种新的纯合突变(R314W)。未受影响的父母无血缘关系,均为该突变的杂合携带者。50名正常个体未携带该突变,排除了常见多态性。
所鉴定的TPO基因突变(R314W)很可能是该报告患儿甲状腺功能减退症的遗传病因。R314W此前未被描述过,编码的可能是一种无活性的TPO分子。